Yes, a 6-year-old child is eligible to receive Kinrix vaccine
A 6-year-old child can receive Kinrix as long as they are still prior to their seventh birthday, making them eligible within the FDA-approved age range of 4 through 6 years. 1
Age Eligibility Requirements
Kinrix is FDA-approved specifically for children aged 4 through 6 years (prior to the seventh birthday) 1. This means:
- A child who is 6 years old but has not yet turned 7 is eligible
- The vaccine must be administered before the child's 7th birthday
- This aligns with the CDC immunization schedule recommending the final DTaP dose at age 4-6 years 2
Important Prerequisites
The child must meet specific vaccination history requirements to receive Kinrix 1:
- Previous DTaP doses: The first 3 doses must have been INFANRIX and/or PEDIARIX
- Fourth dose: Must have been INFANRIX
- Kinrix serves as: The 5th dose in the DTaP series AND the 4th dose in the IPV series
Clinical Context
This combination vaccine reduces the number of injections needed at the 4-6 year well-child visit, which is a critical time for multiple booster vaccinations 3. The vaccine has demonstrated excellent immunogenicity with >95% of children achieving booster responses to diphtheria, tetanus, and pertussis antigens, and 100% achieving seroprotective anti-poliovirus antibody titers 4.
Common Pitfall to Avoid
Do not administer Kinrix if the child has already turned 7 years old - at that point, the child would need Tdap (not DTaP) for their tetanus/diphtheria/pertussis booster, as Tdap formulations are approved for ages 10-11 years and older 2.